ABCB1 and cancer: This phenomenon often involves ATP-binding cassette (ABC) efflux transporters, such as P-glycoprotein (P-gp/ABCB1) and multidrug resistance-associated proteins (MRPs), which actively expel chemotherapeutic agents from cancer cells, thereby reducing their intracellular concentrations and therapeutic efficacy [9,10].